MI
VRTX icon

Motiv8 Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Motiv8 Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26 Buy
+58
New +$25K 0.01% 348
2024
Q4 		– Sell
-1,620
Closed -$753K – 100
2024
Q3 		$753K Buy
1,620
+3
+0.2% +$1.44K 0.51% 64
2024
Q2 		$758K Buy
1,617
+207
+15% +$89.8K 0.56% 53
2024
Q1 		$589K Buy
1,410
+280
+25% +$118K 0.46% 68
2023
Q4 		$460K Buy
+1,130
New +$417K 0.41% 70

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Motiv8 Investments's VRTX Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2025: 58 shares worth $26. The stake represents 0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Motiv8 Investments previously reported a position in VRTX as recently as Q3 2024.

Motiv8 Investments first reported a position in VRTX in Q4 2023 and has held it in 5 quarters since. The position peaked at $758K in Q2 2024. 1,669 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Motiv8 Investments held 58 shares of Vertex Pharmaceuticals worth $26 as of Q4 2025.
  • Vertex Pharmaceuticals was a new Motiv8 Investments position in Q4 2025.
  • Vertex Pharmaceuticals made up 0.01% of Motiv8 Investments's portfolio in Q4 2025, its #348 holding.
  • Motiv8 Investments first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Motiv8 Investments's Vertex Pharmaceuticals position peaked at $758K in Q2 2024.
  • 1,669 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.